合成和系统生物技术(英文)(Synthetic and Systems Biotechnology) 知网目次维普目次
- CSCD
- 主管单位:
中国科学院
- 主办单位:
中国科技出版传媒股份有限公司
- 国际刊号:
2097-1206;EISSN 2405-805X
- 国内刊号:
10-1776/Q
- 学科分类:
- 字数:
4000-40000
- 有无基金:
/有基金 100.0%
- 周期:
CN外文-季刊
- 特殊属性:
外文期刊
- 电话:
- 邮箱:
- 复合因子:
0
- 综合因子:
0
- 收录:
知网目次,维普目次
- 级别:
CSCD
期刊简介
《合成和系统生物技术(英文)(Synthetic and Systems Biotechnology)》期刊已被查看: 次
更新频次
单位占比
一作占比
/有基金-100.0%投稿指南
1、投稿方式:在线投稿。
2、官网网址:
http://www.keaipublishing.com/en/journals/synthetic-and-systems-biotechnology/
https://www.sciencedirect.com/journal/synthetic-and-systems-biotechnology
3、投稿网址:
https://www2.cloud.editorialmanager.com/synbio/default2.aspx
4、出刊日期:季刊,逢季末月出版。
2024年2月26日星期一
《合成和系统生物技术(英文)》作者指南
【官网信息】
Guide for Authors
Types of paper
Contributions falling into the following categories will be considered for publication: Original Research Articles, Reviews, and Short Communications.
Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
For further information, visit our Support Center.
BEFORE YOU BEGIN
Ethics in Publishing
For information on Ethics in publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines.
Animal experiments
Does your research involve experimentation on animals? If so, please provide name of the ethical committee approving these experiments and confirm authors' compliance with all relevant ethical regulations.
Human subjects
Does your study include human subjects? If so, please provide name of the ethical committee approving these experiments, confirm authors' compliance with all relevant ethical regulations, and confirm that written consent has been obtained from all patients.
Informed consent
If your manuscript is related to clinical study, please provide following pieces of information and state them in your manuscript: 1) date of IRB approval and the approval number, 2) status of informed consent (IC); [e.g. Was written IC required? Was your clinical study approved without IC? If so, the reason why?]
I confirm that I have obtained all consents required by applicable law for the publication of any personal details or images of patients, research subjects or other individuals that are used in the materials submitted to KeAi. I have retained a written copy of all such consents and I agree to provide KeAi with copies of the consents or evidence that such consents have been obtained if requested by KeAi.
Clinical research must include IRB approval and patient consent forms.
Conflict of Interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
……
更多详情:
http://www.keaipublishing.com/en/journals/synthetic-and-systems-biotechnology/guide-for-authors/
中国全科医学发文选摘
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
《合成和系统生物技术(英文)(Synthetic and Systems Biotechnology)》同类医卫综论期刊
-
医用生物力学
北核,CSCD,科核,武A
CN中文-双月刊影响因子1.164
-
实用医学杂志
北核,科核,武A+
CN中文-半月刊影响因子1.949
-
医学与社会(原:同济医科大学学报.社会科学版)
北核,科核,CACJ-核心,AMI扩,武B+
CN中文-月刊影响因子2.142
-
复旦学报(医学版)
北核,CSCD,科核,武A
CN中文-双月刊影响因子1.332
-
医学与哲学(原:医学与哲学(A)、(B)等)
北核,科核,科核,武A-,AMI扩
CN中文-半月刊影响因子1.425
-
中国全科医学
北核,科核,武A+
CN中文-旬刊影响因子2.882
-
中国医学科学院学报
北核,CSCD,科核,武A
CN中文-双月刊影响因子1.431
-
医学研究与战创伤救治(原:医学研究生学报;金陵医院学报)(不收版面费审稿费)
北核,科核,武A
CN中文-月刊影响因子1.579
常见问题
-
哪些期刊可以用来评职称?
1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。
-
你们的服务可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
请问发表一篇期刊的费用是多少?
期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。
-
如果发表不成功可以退款吗?
如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。
-
请问文章发表需要多长时间?
不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。
-
期刊发表能加急见刊吗?
为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。